- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3340EUR$3,500USD£2,799GBP
- Report
- October 2024
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2338EUR$2,450USD£1,959GBP
- Report
- December 2021
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1432EUR$1,500USD£1,199GBP
The Adenovirus Test is a type of infectious disease test used to detect the presence of adenoviruses in a sample. Adenoviruses are a group of viruses that can cause a range of illnesses, including respiratory, gastrointestinal, and eye infections. The test is used to diagnose adenovirus infections, as well as to monitor the effectiveness of treatments. It is typically performed on a sample of blood, urine, or tissue.
The Adenovirus Test market is a subset of the larger Infectious Disease Testing market. It is a growing market, driven by the increasing prevalence of adenovirus infections and the need for accurate diagnosis and treatment. The market is expected to benefit from advances in technology, such as the development of more sensitive and specific tests.
Some companies in the Adenovirus Test market include Abbott, Becton Dickinson, Cepheid, Hologic, and Roche. Show Less Read more